We find that this MAIT-cell dysfunction is associated with enhanced PD-1 expression upon stimulation, and that the combination of a potent MR-1 ligand with PD-1 blockade enhances MR-1-dependent cytotoxicity against a prostate cancer cell line. Here, PDCD1 is linked to prostate carcinoma.